Good paper from York’s Alison Wilson and colleagues shining a light on the need to improve characterisation of cell populations in reporting of cell therapy research. Especially important if we are to learn from research and share knowledge. https://t.co/g
Characterisation of mesenchymal stromal cells in clinical trial reports: analysis of published descriptors https://t.co/kTmUKOLuMP
RT @norionakatsuji: 最近の「幹細胞治療」で最も多く使用の「間葉系幹細胞＝間葉系間質細胞」“Mesenchymal Stem/Stromal Cell”、専門家は細胞集団（即ち患者や治験参加者に使用）の中身と特性が均一／明確でなく多様な細胞の集合体との認識が多…
RT @norionakatsuji: 最近の「幹細胞治療」で最も多く使用の「間葉系幹細胞＝間葉系間質細胞」“Mesenchymal Stem/Stromal Cell”、専門家は細胞集団（即ち患者や治験参加者に使用）の中身と特性が均一／明確でなく多様な細胞の集合体との認識が多…